Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Associate

Minji Kim

Goodwin Procter

main

Kim Minji

Goodwin Associate Minji Kim, from Silicon Valley, practices in the Business Law Department with an emphasis on life sciences.

Minji Kim

Areas of Practice

Credentials

Education

JD

M1

BS

Admissions

Bars

Related Content

Goodwin Advises Document Crunch in Acquisition by Trimble

Goodwin Advises Abra on Becoming a Public Company via Business Combination With New Providence Acquisition Corp. III

Goodwin Guides Repertoire Immune Medicines on a Strategic Collaboration with Lilly to Develop Tolerizing Therapies for Autoimmune Diseases for $85 Million Upfront, Up to $1.84 Billion in Milestones, and Potential Tiered Royalties

Goodwin Advises AI Proteins on $41.5 Million Series A Financing

Goodwin Advises Braveheart Bio in $185 Million Series A Financing and License Agreement with Hengrui Pharma

The Best Lawyers in America 2026 Honors Goodwin Lawyers Nationwide

Life Sciences